Catalpol inhibits apoptosis in hydrogen peroxide-induced endothelium by activating the PI3K/Akt signaling pathway and modulating expression of Bcl-2 and Bax

Catalpol, an iridoid glucoside found in the root of Rehmannia glutinosa Libosch, has been demonstrated to reduce apoptosis in neuronal cell lines. Recent data suggests that catalpol also exerts anti-apoptotic effects on other cell types. The aim of the present study was to investigate whether catalp...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of pharmacology 2010-02, Vol.628 (1), p.155-163
Hauptverfasser: Hu, Lingai, Sun, Yukun, Hu, Jian
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 163
container_issue 1
container_start_page 155
container_title European journal of pharmacology
container_volume 628
creator Hu, Lingai
Sun, Yukun
Hu, Jian
description Catalpol, an iridoid glucoside found in the root of Rehmannia glutinosa Libosch, has been demonstrated to reduce apoptosis in neuronal cell lines. Recent data suggests that catalpol also exerts anti-apoptotic effects on other cell types. The aim of the present study was to investigate whether catalpol protects against hydrogen peroxide (H 2O 2) induced apoptosis in human umbilical vein endothelial cells (HUVECs). Apoptotic cells were detected by terminal deoxyribonucleotidyl transferase-mediated deoxyuridine triphosphate-biotin nick end labeling, Annexin V-fluorescein isothiocyanate binding assay and by assessment of caspase-3 activity. The level of intracellular reactive oxygen species was quantified by 2′, 7′-dichlorofluorescein diacetate assay. Expression of Akt, Bad, Bcl-2 and Bax mRNA and protein was determined by real-time semiquantitative reverse transcription-polymerase chain reaction and Western blotting. Apoptosis in HUVECs was associated with increased Bax, decreased Bcl-2 activity and inactivated phosphorylation of Akt and Bad after 24 h of H 2O 2 exposure. Pre-treatment of HUVECs with catalpol significantly reduced H 2O 2-induced intracellular reactive oxygen species release. Catalpol not only increased the expression of Bcl-2, while decreasing Bax expression, but also induced Akt activation and Bad phosphorylation, and ultimately reduced H 2O 2-induced apoptosis. The protective effects of catalpol were partially inhibited by the phosphatidylinositol 3-kinase (PI3K) antagonist wortmannin or 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). Taken together, these results suggest that pre-treatment of HUVECs with catalpol can block H 2O 2-induced apoptosis, and that the underlying mechanism involves reactive oxygen species scavenging, activation of the PI3K/Akt–Bad signaling pathway and increased Bcl-2 and decreased Bax expression.
doi_str_mv 10.1016/j.ejphar.2009.11.046
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_733850853</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S001429990901098X</els_id><sourcerecordid>733850853</sourcerecordid><originalsourceid>FETCH-LOGICAL-c457t-43badf3ece32369125172210cc92f1300f17ce26b03fffe834253e9ef00418043</originalsourceid><addsrcrecordid>eNp9kctu1DAUhiMEotPCGyDkDWKV1JfcvEFqRxQqKsEC1pbjHE88JHawnTLzLjwsHjKCHasj_frORefLslcEFwST-npfwH4epC8oxrwgpMBl_STbkLbhOW4IfZptMCZlTjnnF9llCHuMccVp9Ty7IJzXlDf1Jvu1lVGOsxuRsYPpTAxIzm6OLpiQIjQce-92YNEM3h1MD7mx_aKgR2B7FwcYzTKh7oikiuZRRmN3KKXoyz37dH3zPaJgdlaOp3iWcfgpE2l7NLl-GVcaDrOHEIyzyGl0q8ac_kFu5eFF9kzLMcDLc73Kvt29_7r9mD98_nC_vXnIVVk1MS9ZJ3vNQAGjrOaEVqShlGClONWEYaxJo4DWHWZaa2hZSSsGHDTGJWlxya6yt-vc2bsfC4QoJhMUjKO04JYgGsbaCrcVS2S5ksq7EDxoMXszSX8UBIuTFrEXqxZx0iIIEUlLant9XrB0E_T_ms4eEvDmDMig5Ki9tMqEvxylZZM8Nol7t3KQ3vFowIugDNjkw3hQUfTO_P-S35_nr0Y</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>733850853</pqid></control><display><type>article</type><title>Catalpol inhibits apoptosis in hydrogen peroxide-induced endothelium by activating the PI3K/Akt signaling pathway and modulating expression of Bcl-2 and Bax</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Hu, Lingai ; Sun, Yukun ; Hu, Jian</creator><creatorcontrib>Hu, Lingai ; Sun, Yukun ; Hu, Jian</creatorcontrib><description>Catalpol, an iridoid glucoside found in the root of Rehmannia glutinosa Libosch, has been demonstrated to reduce apoptosis in neuronal cell lines. Recent data suggests that catalpol also exerts anti-apoptotic effects on other cell types. The aim of the present study was to investigate whether catalpol protects against hydrogen peroxide (H 2O 2) induced apoptosis in human umbilical vein endothelial cells (HUVECs). Apoptotic cells were detected by terminal deoxyribonucleotidyl transferase-mediated deoxyuridine triphosphate-biotin nick end labeling, Annexin V-fluorescein isothiocyanate binding assay and by assessment of caspase-3 activity. The level of intracellular reactive oxygen species was quantified by 2′, 7′-dichlorofluorescein diacetate assay. Expression of Akt, Bad, Bcl-2 and Bax mRNA and protein was determined by real-time semiquantitative reverse transcription-polymerase chain reaction and Western blotting. Apoptosis in HUVECs was associated with increased Bax, decreased Bcl-2 activity and inactivated phosphorylation of Akt and Bad after 24 h of H 2O 2 exposure. Pre-treatment of HUVECs with catalpol significantly reduced H 2O 2-induced intracellular reactive oxygen species release. Catalpol not only increased the expression of Bcl-2, while decreasing Bax expression, but also induced Akt activation and Bad phosphorylation, and ultimately reduced H 2O 2-induced apoptosis. The protective effects of catalpol were partially inhibited by the phosphatidylinositol 3-kinase (PI3K) antagonist wortmannin or 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). Taken together, these results suggest that pre-treatment of HUVECs with catalpol can block H 2O 2-induced apoptosis, and that the underlying mechanism involves reactive oxygen species scavenging, activation of the PI3K/Akt–Bad signaling pathway and increased Bcl-2 and decreased Bax expression.</description><identifier>ISSN: 0014-2999</identifier><identifier>EISSN: 1879-0712</identifier><identifier>DOI: 10.1016/j.ejphar.2009.11.046</identifier><identifier>PMID: 19962976</identifier><identifier>CODEN: EJPHAZ</identifier><language>eng</language><publisher>Amsterdam: Elsevier B.V</publisher><subject>Animals ; Apoptosis ; Apoptosis - drug effects ; bcl-2-Associated X Protein - metabolism ; Biological and medical sciences ; Catalpol ; Cell Survival - drug effects ; Endothelial Cells - cytology ; Endothelial Cells - drug effects ; Endothelial Cells - metabolism ; Endothelium, Vascular - cytology ; Endothelium, Vascular - drug effects ; Endothelium, Vascular - metabolism ; Free Radical Scavengers - pharmacology ; Gene Expression Regulation - drug effects ; Humans ; HUVEC ; Hydrogen peroxide ; Hydrogen Peroxide - pharmacology ; Medical sciences ; Pharmacology. Drug treatments ; Phosphatidylinositol 3-Kinases - metabolism ; Phosphorylation - drug effects ; Proto-Oncogene Proteins c-akt - metabolism ; Proto-Oncogene Proteins c-bcl-2 - metabolism ; Quaternary Ammonium Compounds - pharmacology ; Reactive Oxygen Species - metabolism ; Signal Transduction - drug effects ; Umbilical Veins - cytology</subject><ispartof>European journal of pharmacology, 2010-02, Vol.628 (1), p.155-163</ispartof><rights>2009 Elsevier B.V.</rights><rights>2015 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c457t-43badf3ece32369125172210cc92f1300f17ce26b03fffe834253e9ef00418043</citedby><cites>FETCH-LOGICAL-c457t-43badf3ece32369125172210cc92f1300f17ce26b03fffe834253e9ef00418043</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S001429990901098X$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=22472997$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19962976$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hu, Lingai</creatorcontrib><creatorcontrib>Sun, Yukun</creatorcontrib><creatorcontrib>Hu, Jian</creatorcontrib><title>Catalpol inhibits apoptosis in hydrogen peroxide-induced endothelium by activating the PI3K/Akt signaling pathway and modulating expression of Bcl-2 and Bax</title><title>European journal of pharmacology</title><addtitle>Eur J Pharmacol</addtitle><description>Catalpol, an iridoid glucoside found in the root of Rehmannia glutinosa Libosch, has been demonstrated to reduce apoptosis in neuronal cell lines. Recent data suggests that catalpol also exerts anti-apoptotic effects on other cell types. The aim of the present study was to investigate whether catalpol protects against hydrogen peroxide (H 2O 2) induced apoptosis in human umbilical vein endothelial cells (HUVECs). Apoptotic cells were detected by terminal deoxyribonucleotidyl transferase-mediated deoxyuridine triphosphate-biotin nick end labeling, Annexin V-fluorescein isothiocyanate binding assay and by assessment of caspase-3 activity. The level of intracellular reactive oxygen species was quantified by 2′, 7′-dichlorofluorescein diacetate assay. Expression of Akt, Bad, Bcl-2 and Bax mRNA and protein was determined by real-time semiquantitative reverse transcription-polymerase chain reaction and Western blotting. Apoptosis in HUVECs was associated with increased Bax, decreased Bcl-2 activity and inactivated phosphorylation of Akt and Bad after 24 h of H 2O 2 exposure. Pre-treatment of HUVECs with catalpol significantly reduced H 2O 2-induced intracellular reactive oxygen species release. Catalpol not only increased the expression of Bcl-2, while decreasing Bax expression, but also induced Akt activation and Bad phosphorylation, and ultimately reduced H 2O 2-induced apoptosis. The protective effects of catalpol were partially inhibited by the phosphatidylinositol 3-kinase (PI3K) antagonist wortmannin or 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). Taken together, these results suggest that pre-treatment of HUVECs with catalpol can block H 2O 2-induced apoptosis, and that the underlying mechanism involves reactive oxygen species scavenging, activation of the PI3K/Akt–Bad signaling pathway and increased Bcl-2 and decreased Bax expression.</description><subject>Animals</subject><subject>Apoptosis</subject><subject>Apoptosis - drug effects</subject><subject>bcl-2-Associated X Protein - metabolism</subject><subject>Biological and medical sciences</subject><subject>Catalpol</subject><subject>Cell Survival - drug effects</subject><subject>Endothelial Cells - cytology</subject><subject>Endothelial Cells - drug effects</subject><subject>Endothelial Cells - metabolism</subject><subject>Endothelium, Vascular - cytology</subject><subject>Endothelium, Vascular - drug effects</subject><subject>Endothelium, Vascular - metabolism</subject><subject>Free Radical Scavengers - pharmacology</subject><subject>Gene Expression Regulation - drug effects</subject><subject>Humans</subject><subject>HUVEC</subject><subject>Hydrogen peroxide</subject><subject>Hydrogen Peroxide - pharmacology</subject><subject>Medical sciences</subject><subject>Pharmacology. Drug treatments</subject><subject>Phosphatidylinositol 3-Kinases - metabolism</subject><subject>Phosphorylation - drug effects</subject><subject>Proto-Oncogene Proteins c-akt - metabolism</subject><subject>Proto-Oncogene Proteins c-bcl-2 - metabolism</subject><subject>Quaternary Ammonium Compounds - pharmacology</subject><subject>Reactive Oxygen Species - metabolism</subject><subject>Signal Transduction - drug effects</subject><subject>Umbilical Veins - cytology</subject><issn>0014-2999</issn><issn>1879-0712</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kctu1DAUhiMEotPCGyDkDWKV1JfcvEFqRxQqKsEC1pbjHE88JHawnTLzLjwsHjKCHasj_frORefLslcEFwST-npfwH4epC8oxrwgpMBl_STbkLbhOW4IfZptMCZlTjnnF9llCHuMccVp9Ty7IJzXlDf1Jvu1lVGOsxuRsYPpTAxIzm6OLpiQIjQce-92YNEM3h1MD7mx_aKgR2B7FwcYzTKh7oikiuZRRmN3KKXoyz37dH3zPaJgdlaOp3iWcfgpE2l7NLl-GVcaDrOHEIyzyGl0q8ac_kFu5eFF9kzLMcDLc73Kvt29_7r9mD98_nC_vXnIVVk1MS9ZJ3vNQAGjrOaEVqShlGClONWEYaxJo4DWHWZaa2hZSSsGHDTGJWlxya6yt-vc2bsfC4QoJhMUjKO04JYgGsbaCrcVS2S5ksq7EDxoMXszSX8UBIuTFrEXqxZx0iIIEUlLant9XrB0E_T_ms4eEvDmDMig5Ki9tMqEvxylZZM8Nol7t3KQ3vFowIugDNjkw3hQUfTO_P-S35_nr0Y</recordid><startdate>20100225</startdate><enddate>20100225</enddate><creator>Hu, Lingai</creator><creator>Sun, Yukun</creator><creator>Hu, Jian</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20100225</creationdate><title>Catalpol inhibits apoptosis in hydrogen peroxide-induced endothelium by activating the PI3K/Akt signaling pathway and modulating expression of Bcl-2 and Bax</title><author>Hu, Lingai ; Sun, Yukun ; Hu, Jian</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c457t-43badf3ece32369125172210cc92f1300f17ce26b03fffe834253e9ef00418043</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Animals</topic><topic>Apoptosis</topic><topic>Apoptosis - drug effects</topic><topic>bcl-2-Associated X Protein - metabolism</topic><topic>Biological and medical sciences</topic><topic>Catalpol</topic><topic>Cell Survival - drug effects</topic><topic>Endothelial Cells - cytology</topic><topic>Endothelial Cells - drug effects</topic><topic>Endothelial Cells - metabolism</topic><topic>Endothelium, Vascular - cytology</topic><topic>Endothelium, Vascular - drug effects</topic><topic>Endothelium, Vascular - metabolism</topic><topic>Free Radical Scavengers - pharmacology</topic><topic>Gene Expression Regulation - drug effects</topic><topic>Humans</topic><topic>HUVEC</topic><topic>Hydrogen peroxide</topic><topic>Hydrogen Peroxide - pharmacology</topic><topic>Medical sciences</topic><topic>Pharmacology. Drug treatments</topic><topic>Phosphatidylinositol 3-Kinases - metabolism</topic><topic>Phosphorylation - drug effects</topic><topic>Proto-Oncogene Proteins c-akt - metabolism</topic><topic>Proto-Oncogene Proteins c-bcl-2 - metabolism</topic><topic>Quaternary Ammonium Compounds - pharmacology</topic><topic>Reactive Oxygen Species - metabolism</topic><topic>Signal Transduction - drug effects</topic><topic>Umbilical Veins - cytology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hu, Lingai</creatorcontrib><creatorcontrib>Sun, Yukun</creatorcontrib><creatorcontrib>Hu, Jian</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hu, Lingai</au><au>Sun, Yukun</au><au>Hu, Jian</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Catalpol inhibits apoptosis in hydrogen peroxide-induced endothelium by activating the PI3K/Akt signaling pathway and modulating expression of Bcl-2 and Bax</atitle><jtitle>European journal of pharmacology</jtitle><addtitle>Eur J Pharmacol</addtitle><date>2010-02-25</date><risdate>2010</risdate><volume>628</volume><issue>1</issue><spage>155</spage><epage>163</epage><pages>155-163</pages><issn>0014-2999</issn><eissn>1879-0712</eissn><coden>EJPHAZ</coden><abstract>Catalpol, an iridoid glucoside found in the root of Rehmannia glutinosa Libosch, has been demonstrated to reduce apoptosis in neuronal cell lines. Recent data suggests that catalpol also exerts anti-apoptotic effects on other cell types. The aim of the present study was to investigate whether catalpol protects against hydrogen peroxide (H 2O 2) induced apoptosis in human umbilical vein endothelial cells (HUVECs). Apoptotic cells were detected by terminal deoxyribonucleotidyl transferase-mediated deoxyuridine triphosphate-biotin nick end labeling, Annexin V-fluorescein isothiocyanate binding assay and by assessment of caspase-3 activity. The level of intracellular reactive oxygen species was quantified by 2′, 7′-dichlorofluorescein diacetate assay. Expression of Akt, Bad, Bcl-2 and Bax mRNA and protein was determined by real-time semiquantitative reverse transcription-polymerase chain reaction and Western blotting. Apoptosis in HUVECs was associated with increased Bax, decreased Bcl-2 activity and inactivated phosphorylation of Akt and Bad after 24 h of H 2O 2 exposure. Pre-treatment of HUVECs with catalpol significantly reduced H 2O 2-induced intracellular reactive oxygen species release. Catalpol not only increased the expression of Bcl-2, while decreasing Bax expression, but also induced Akt activation and Bad phosphorylation, and ultimately reduced H 2O 2-induced apoptosis. The protective effects of catalpol were partially inhibited by the phosphatidylinositol 3-kinase (PI3K) antagonist wortmannin or 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). Taken together, these results suggest that pre-treatment of HUVECs with catalpol can block H 2O 2-induced apoptosis, and that the underlying mechanism involves reactive oxygen species scavenging, activation of the PI3K/Akt–Bad signaling pathway and increased Bcl-2 and decreased Bax expression.</abstract><cop>Amsterdam</cop><pub>Elsevier B.V</pub><pmid>19962976</pmid><doi>10.1016/j.ejphar.2009.11.046</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0014-2999
ispartof European journal of pharmacology, 2010-02, Vol.628 (1), p.155-163
issn 0014-2999
1879-0712
language eng
recordid cdi_proquest_miscellaneous_733850853
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects Animals
Apoptosis
Apoptosis - drug effects
bcl-2-Associated X Protein - metabolism
Biological and medical sciences
Catalpol
Cell Survival - drug effects
Endothelial Cells - cytology
Endothelial Cells - drug effects
Endothelial Cells - metabolism
Endothelium, Vascular - cytology
Endothelium, Vascular - drug effects
Endothelium, Vascular - metabolism
Free Radical Scavengers - pharmacology
Gene Expression Regulation - drug effects
Humans
HUVEC
Hydrogen peroxide
Hydrogen Peroxide - pharmacology
Medical sciences
Pharmacology. Drug treatments
Phosphatidylinositol 3-Kinases - metabolism
Phosphorylation - drug effects
Proto-Oncogene Proteins c-akt - metabolism
Proto-Oncogene Proteins c-bcl-2 - metabolism
Quaternary Ammonium Compounds - pharmacology
Reactive Oxygen Species - metabolism
Signal Transduction - drug effects
Umbilical Veins - cytology
title Catalpol inhibits apoptosis in hydrogen peroxide-induced endothelium by activating the PI3K/Akt signaling pathway and modulating expression of Bcl-2 and Bax
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T23%3A20%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Catalpol%20inhibits%20apoptosis%20in%20hydrogen%20peroxide-induced%20endothelium%20by%20activating%20the%20PI3K/Akt%20signaling%20pathway%20and%20modulating%20expression%20of%20Bcl-2%20and%20Bax&rft.jtitle=European%20journal%20of%20pharmacology&rft.au=Hu,%20Lingai&rft.date=2010-02-25&rft.volume=628&rft.issue=1&rft.spage=155&rft.epage=163&rft.pages=155-163&rft.issn=0014-2999&rft.eissn=1879-0712&rft.coden=EJPHAZ&rft_id=info:doi/10.1016/j.ejphar.2009.11.046&rft_dat=%3Cproquest_cross%3E733850853%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=733850853&rft_id=info:pmid/19962976&rft_els_id=S001429990901098X&rfr_iscdi=true